Youi to back Blue Zebra after Zurich’s withdrawal
February 27 2020 by Andrew Tjaardstra
-
Mitsui Sumitomo to offer Australia SME capacity to Argyle Insurance
- November 15
The multi-year agreement, starting January 1, 2025, will offer business insurance packages with an extended combined limit of up to US$4.52m.
-
Australian MGA Criterion expands into environmental impairment liability, D&O, casualty
- November 12
The waste and recycling specialist is also planning to launch professional indemnity coverage, says underwriting director Stuart Kinsella.
-
London Australia Underwriting appoints head of new wholesale division
- November 11
Sydney-based Holly Blower will head the new division, which will complement the MGA's extensive binder business to assist with hard to place opportunities.
-
APRA applies additional US$6.6m capital requirement to Pacific International Insurance
- November 1
The regulator identified fundamental deficiencies in Pacific’s oversight and control of its existing binder holder business and risk management framework, including weaknesses in accountability and adequacy of resourcing.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
